Related Experiment Video
Updated: Aug 14, 2025

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
Challenges to Using Big Data in Cancer
Shawn M Sweeney1, Hisham K Hamadeh2, Natalie Abrams3
1American Association for Cancer Research, Philadelphia, Pennsylvania.
Cancer Research
|January 10, 2023
Summary
Big data in healthcare offers deep insights into diseases and treatments, especially in oncology. Overcoming challenges in data interoperability, quality, and privacy is key to unlocking its full medical potential.
Area of Science:
- Healthcare Informatics
- Medical Data Science
- Oncology Research
Background:
- Big data analytics in healthcare provides novel insights into disease understanding and treatment strategies.
- Healthcare data encompasses electronic health records, medical imaging, genomic sequencing, and data from wearables and devices.
Purpose of the Study:
- To highlight the critical role of big data in advancing medical understanding, particularly in oncology.
- To identify key challenges and considerations for the effective utilization of big data in healthcare.
Main Methods:
- Review of current big data applications and challenges in healthcare.
- Analysis of data interoperability, quality, and privacy concerns.
- Examination of regulatory frameworks like HIPAA, Common Rule, and GDPR.
Main Results:
- Combining diverse healthcare datasets is essential but hindered by interoperability and data quality issues.
- Data privacy regulations (HIPAA, Common Rule, GDPR) are significant considerations.
- Regulatory bodies like the FDA and EMA are integrating big data into their planning.
Conclusions:
- Addressing data interoperability, quality standards, and privacy tenets is crucial for realizing big data's potential in medicine.
- Collaborative, precompetitive data sharing is vital for advancing medical research and application.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
411
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
411
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K

